American Journal of Neuroradiology 26:1178-1185, May 2005
© 2005 American Society of Neuroradiology
HEAD AND NECK
Perfusion CT for Head and Neck Tumors: Pilot Study
a From the Department of Radiology, Medical University of South Carolina, Charleston
Address reprint requests to Zoran Rumboldt, MD, Department of Radiology, Medical University of South Carolina, 169 Ashley Avenue, P. O. Box 250322, Charleston, SC 29425
BACKGROUND AND PURPOSE: Differentiation of malignant from benign head and neck lesions is often very difficult on imaging studies, especially in patients with treated cancer. We evaluated the feasibility and reproducibility of perfusion CT (CTP) after enhanced head and neck CT and attempted to differentiate benign from malignant processes.
METHODS: CTP was attempted in 17 patients after head and neck contrast-enhanced CT. Data were postprocessed by using deconvolution-based perfusion analysis. Ipsilateral and contralateral internal, external, and common carotid arteries were used as arterial input vessels. Postprocessing-generated maps showed mean transit time (MTT), blood volume, blood flow, and capillary permeability surface product. Two readers independently placed regions of interest through the primary site, salivary glands, thyroid gland, paraspinous muscles, muscles of mastication, sternocleidomastoid muscle, base of tongue, and subcutaneous fat. One reader repeated the measurements on separate dates. Data were statistically analyzed, and histologic specimens were obtained.
RESULTS: CTP was not possible in four patients, and one was lost to follow-up. Of the remaining 12, five had cancer, and seven had benign processes. We found no significant interreader or intrareader differences and no significant difference between various input vessels. Differentiation between malignant and nonmalignant lesions was most reliable by using MTTs. Measurements were comparable to those in the literature.
CONCLUSION: CTP after enhanced head and neck CT is feasible, except perhaps at the laryngeal level. It appears to be reader independent and reproducible regardless of the input vessel. CTP shows promise in distinguishing benign and malignant processes, primarily by means of MTTs.
This article has been cited by other articles:
 |
|
 |
|
  L. Faggioni, E. Neri, and C. Bartolozzi CT Perfusion of Head and Neck Tumors: How We Do It Am. J. Roentgenol., January 1, 2010; 194(1): 62 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.C. Miracle, A. Rezaei, D. Gandhi, and S.K. Mukherji CT Perfusion of the Neck: Internal Carotid Artery versus External Carotid Artery as the Reference Artery AJNR Am. J. Neuroradiol., September 1, 2009; 30(8): 1598 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Petralia, L. Preda, S. Raimondi, G. D'Andrea, P. Summers, G. Giugliano, F. Chiesa, and M. Bellomi Intra- and Interobserver Agreement and Impact of Arterial Input Selection in Perfusion CT Measurements Performed in Squamous Cell Carcinoma of the Upper Aerodigestive Tract AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1107 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ash, T. N. Teknos, D. Gandhi, S. Patel, and S. K. Mukherji Head and Neck Squamous Cell Carcinoma: CT Perfusion Can Help Noninvasively Predict Intratumoral Microvessel Density Radiology, May 1, 2009; 251(2): 422 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bisdas, Z. Rumboldt, J. Wagenblast, M. Baghi, T.S. Koh, M. Hambek, T.J. Vogl, and M.G. Mack Response and Progression-Free Survival in Oropharynx Squamous Cell Carcinoma Assessed by Pretreatment Perfusion CT: Comparison with Tumor Volume Measurements AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bisdas, K. Spicer, and Z. Rumboldt Whole-Tumor Perfusion CT Parameters and Glucose Metabolism Measurements in Head and Neck Squamous Cell Carcinomas: A Pilot Study Using Combined Positron-Emission Tomography/CT Imaging AJNR Am. J. Neuroradiol., August 1, 2008; 29(7): 1376 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. X. Zhu, N. S. Holalkere, A. Muzikansky, K. Horgan, and D. V. Sahani Early Antiangiogenic Activity of Bevacizumab Evaluated by Computed Tomography Perfusion Scan in Patients with Advanced Hepatocellular Carcinoma Oncologist, February 1, 2008; 13(2): 120 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zima, R. Carlos, D. Gandhi, I. Case, T. Teknos, and S.K. Mukherji Can Pretreatment CT Perfusion Predict Response of Advanced Squamous Cell Carcinoma of the Upper Aerodigestive Tract Treated with Induction Chemotherapy? AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 328 - 334. [Abstract] [Full Text] [PDF]
|
|